These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1982747)

  • 1. Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
    Robin AL; Coleman AL
    Trans Am Ophthalmol Soc; 1990; 88():149-59; discussion 159-62. PubMed ID: 1982747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.
    Coleman AL; Robin AL; Pollack IP; Rudikoff MT; Enger C; Mayer PR
    Arch Ophthalmol; 1990 Sep; 108(9):1264-7. PubMed ID: 2205182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.
    Stewart WC; Laibovitz R; Horwitz B; Stewart RH; Ritch R; Kottler M
    Arch Ophthalmol; 1996 Aug; 114(8):938-42. PubMed ID: 8694728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.
    Stewart WC; Ritch R; Shin DH; Lehmann RP; Shrader CE; van Buskirk EM
    Arch Ophthalmol; 1995 Mar; 113(3):287-92. PubMed ID: 7887841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME; Robin AL; Cummings HL; Arkin LM
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
    Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
    Morrison JC; Robin AL
    Ophthalmology; 1989 Jan; 96(1):3-7. PubMed ID: 2645550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms.
    Oruç S; Sener EC
    Int Ophthalmol; 1999; 23(2):69-73. PubMed ID: 11196122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery.
    Sciscio A; Casswell AG
    Br J Ophthalmol; 2001 Feb; 85(2):164-8. PubMed ID: 11159479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect of 1% apraclonidine hydrochloride to nonselective beta-blockers.
    Yaldo MK; Shin DH; Parrow KA; Lee SH; Lee SY
    Ophthalmology; 1991 Jul; 98(7):1075-8. PubMed ID: 1679916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Topically Applied 0.5% Apraclonidine Versus 0.5% Timolol Maleate on Intraocular Pressure of Healthy Horses.
    Ziadi A; Ozmaie S; Asghari A; Rajaei SM
    J Equine Vet Sci; 2022 Apr; 111():103886. PubMed ID: 35093487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin DH; Smythe B; Mundorf T; Lehmann RP
    Am J Ophthalmol; 1995 Oct; 120(4):423-32. PubMed ID: 7573299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect and side effects of apraclonidine].
    Stewart WC
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):A7-13. PubMed ID: 8965469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.
    Yüksel N; Güler C; Caglar Y; Elibol O
    Int Ophthalmol; 1992 Sep; 16(4-5):337-42. PubMed ID: 1358852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of apraclonidine in long-term timolol users.
    Gharagozloo NZ; Brubaker RF
    Ophthalmology; 1991 Oct; 98(10):1543-6. PubMed ID: 1683697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.